Is botulinum toxin useful in treating headache? No

被引:0
作者
Mark Obermann
Hans-Christoph Diener
机构
[1] University of Duisburg-Essen,Department of Neurology
来源
Current Treatment Options in Neurology | 2009年 / 11卷
关键词
Migraine; Botulinum Toxin; Chronic Migraine; Chronic Daily Headache; Cervical Dystonia;
D O I
暂无
中图分类号
学科分类号
摘要
The discrepancy between the widespread use of botulinum neurotoxin (BoNT) in managing headache and the supporting clinical evidence is unprecedented. No substance seems to have inspired more physicians and patients to undertake spirited treatment attempts. Tremendous treatment success in small, uncontrolled clinical trials has been repeatedly reported, but no substance that has been studied to an equal extent has so utterly failed to provide proof of effect in controlled clinical trials. Nevertheless, even though most randomized, controlled clinical trials have not met their defined primary outcome criterion, BoNT is still considered a promising treatment alternative for primary headache disorders.
引用
收藏
页码:24 / 31
页数:7
相关论文
共 181 条
[31]  
Zangaglia R.(2000)An association between migraine and cutaneous allodynia Ann Neurol 47 614-685
[32]  
Cristina S.(2003)Botulinum toxin injections for headache Headache 43 682-S33
[33]  
Schnider P.(2003)Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside Headache 43 S25-830
[34]  
Binder M.(2004)Botulinum toxin type A for the treatment of headache: pro Headache 44 825-450
[35]  
Auff E.(2000)Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group Headache 40 445-65
[36]  
Edvinsson L.(2004)Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study Cephalalgia 24 60-676
[37]  
Ishikawa H.(2000)Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study Otolaryngol Head Neck Surg 123 669-1203
[38]  
Mitsui Y.(2001)The first world report of botulinum A toxin injection for status migrainosus J Med Assoc Thai 84 1199-1446
[39]  
Yoshitomi T.(1999)Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia Neurology 53 1439-393
[40]  
Welch M.J.(2007)Myofascial trigger points and sensitization: an updated pain model for tension-type headache Cephalalgia 27 383-531